Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;17(2):295-313.
doi: 10.1002/alz.12202. Epub 2020 Nov 20.

Dementia in Latin America: Paving the way toward a regional action plan

Mario Alfredo Parra  1 Sandra Baez  2 Lucas Sedeño  3 Cecilia Gonzalez Campo  4 Hernando Santamaría-García  5 Ivan Aprahamian  6 Paulo Hf Bertolucci  7 Julian Bustin  8 Maria Aparecida Camargos Bicalho  9 Carlos Cano-Gutierrez  10 Paulo Caramelli  11 Marcia L F Chaves  12 Patricia Cogram  13 Bárbara Costa Beber  14 Felipe A Court  15 Leonardo Cruz de Souza  11 Nilton Custodio  16 Andres Damian  17 Myriam de la Cruz  18 Roberta Diehl Rodriguez  19 Sonia Maria Dozzi Brucki  20 Lais Fajersztajn  21 Gonzalo A Farías  22 Fernanda G De Felice  23 Raffaele Ferrari  24 Fabricio Ferreira de Oliveira  7 Sergio T Ferreira  25 Ceres Ferretti  26 Marcio Luiz Figueredo Balthazar  27 Norberto Anizio Ferreira Frota  28 Patricio Fuentes  29 Adolfo M García  30 Patricia J Garcia  31 Fábio Henrique de Gobbi Porto  32 Lissette Duque Peñailillo  33 Henry Willy Engler  34 Irene Maier  35 Ignacio F Mata  36 Christian Gonzalez-Billault  37 Oscar L Lopez  38 Laura Morelli  39 Ricardo Nitrini  40 Yakeel T Quiroz  41 Alejandra Guerrero Barragan  42 David Huepe  43 Fabricio Joao Pio  44 Claudia Kimie Suemoto  45 Renata Kochhann  46 Silvia Kochen  47 Fiona Kumfor  48 Serggio Lanata  49 Bruce Miller  49 Leticia Lessa Mansur  50 Mirna Lie Hosogi  51 Patricia Lillo  52 Jorge Llibre Guerra  53 David Lira  16 Francisco Lopera  54 Adelina Comas  55 José Alberto Avila-Funes  56 Ana Luisa Sosa  57 Claudia Ramos  58 Elisa de Paula França Resende  58 Heather M Snyder  59 Ioannis Tarnanas  18   35 Jenifer Yokoyama  49 Juan Llibre  60 Juan Felipe Cardona  61 Kate Possin  49 Kenneth S Kosik  62 Rosa Montesinos  16 Sebastian Moguilner  58 Patricia Cristina Lourdes Solis  47 Renata Eloah de Lucena Ferretti-Rebustini  63 Jeronimo Martin Ramirez  64 Diana Matallana  65 Lingani Mbakile-Mahlanza  66 Alyne Mendonça Marques Ton  67 Ronnielly Melo Tavares  68 Eliane C Miotto  69 Graciela Muniz-Terrera  70 Luis Arnoldo Muñoz-Nevárez  71 David Orozco  72 Maira Okada de Oliveira  58 Olivier Piguet  73 Maritza Pintado Caipa  58 Stefanie Danielle Piña Escudero  58 Lucas Porcello Schilling  74 André Luiz Rodrigues Palmeira  75 Mônica Sanches Yassuda  76 Jose Manuel Santacruz-Escudero  77 Rodrigo Bernardo Serafim  78 Jerusa Smid  79 Andrea Slachevsky  80 Cecilia Serrano  81 Marcio Soto-Añari  82 Leonel Tadao Takada  83 Lea Tenenholz Grinberg  84 Antonio Lucio Teixeira  85 Maira Tonidandel Barbosa  86 Dominic Trépel  87 Agustin Ibanez  88
Affiliations

Dementia in Latin America: Paving the way toward a regional action plan

Mario Alfredo Parra et al. Alzheimers Dement. 2021 Feb.

Abstract

Across Latin American and Caribbean countries (LACs), the fight against dementia faces pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic disparities. These can be addressed more effectively in a collaborative setting that fosters open exchange of knowledge. In this work, the Latin American and Caribbean Consortium on Dementia (LAC-CD) proposes an agenda for integration to deliver a Knowledge to Action Framework (KtAF). First, we summarize evidence-based strategies (epidemiology, genetics, biomarkers, clinical trials, nonpharmacological interventions, networking, and translational research) and align them to current global strategies to translate regional knowledge into transformative actions. Then we characterize key sources of complexity (genetic isolates, admixture in populations, environmental factors, and barriers to effective interventions), map them to the above challenges, and provide the basic mosaics of knowledge toward a KtAF. Finally, we describe strategies supporting the knowledge creation stage that underpins the translational impact of KtAF.

Keywords: Latin America; biomarkers; clinical trials; dementia; epidemiology; evidence-based recommendations; genetics; knowledge to action framework; networking and translational research; nonpharmacological interventions.

PubMed Disclaimer

Conflict of interest statement

The Expert Meeting was supported by Alzheimer's Society UK grants awarded to MP in collaboration with AI (AS‐R42303, AS‐SF‐14‐008). AS is supported by CONICYT / FONDAP /15150012; Conicyt/ Fondecyt Regular/ 1140423 and Basal Funds for Centers of Excellence, Project FB 0003 from the Associative Research Program of CONICYT. FL is supported by a grant API COLOMBIA funded by GENENTECH and Banner Institute. FK is supported by a National Health and Medical Research Council of Australia (NHMRC)‐Australian Research Council Dementia Research Development Fellowship (APP1097026). OP is supported by an NHMRC Senior Research Fellowship (APP1103258). FFDO is supported by FAPESP ‐ The State of São Paulo Research Foundation (grant #2015/10109‐5). The support from Alzheimer´s Scotland Dementia Research and the Centre for Cognitive Ageing and Cognitive Epidemiology part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1) both from the University of Edinburgh is also acknowledged. FS is supported by Geroscience Center for Brain Health and Metabolism (FONDAP‐15150012) and Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT, No. 1150766). RAV is supported by CONICYT AFB 170008 and by Faculty of Sciences, University of Chile, PAIFAC grant. PC is supported by CNPq, Brazil (bolsa de produtividade em pesquisa). PL is supported by FONDAP Program Grant 15150012 & by Conicyt/Fondecyt Regular/ 1160940. STF is supported by National Institute for Translational Neuroscience (Brazil, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil). BCB is supported by Alzheimer's Association and Global Brain Health Institute (GBHI_ALZ‐18‐542347). LTG is supported by NIH K24AG053435. MLFC is supported by CNPq (bolsa de produtividade em pesquisa). RDR is supported by FAPESP (2016/24326‐0) and the Alzheimer´s Association (AARF‐18‐566005). LD is partially supported by Neuromedicenter. RF is supported by Alzheimer's Society (grant # 284). LCS is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil). MSY is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and São Paulo Research Foundation (FAPESP/BRAZIL). MACB is supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) and Minas Gerais Research Foundation (FAPEMIG/BRAZIL). IA receives National public grant level 2 from the National Council for Scientific and Technological Development (Ministry of Science, Technology, Innovation and Communications, Brazil). HMS is a full‐time employee of the Alzheimer's Association. AI is partially supported by grants from CONICET, FONCyT‐PICT 2017‐1818, FONCyT‐PICT 2017‐1820, FONDAP 15150012, the Interamerican Development Bank (IDB), Alzheimer's Association GBHI ALZ UK‐20‐639295, and the MULTI‐PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICA [ReDLat, supported by National Institutes of Health, National Institute on Aging (R01 AG057234), Alzheimer's Association (SG‐20‐725707), Tau Consortium, and Global Brain Health Institute)]. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these Institutions. The other authors declare no conflict of interests.

Figures

FIGURE 1
FIGURE 1
Priority levels assigned to core areas and challenges via a knowledge inquiry and related actions timelines. Co‐authors of this work were presented with a survey and were asked to rank the five areas and associated challenges in order of priority. We calculated the percentage of respondents who rated these within the top two priorities and used these to rank both areas and challenges. The right inset shows the timeline for the proposed actions described in Section 4. Experts were also asked to deliver their views about a feasible timeline to address these challenges and actions (0‐5 or 5‐10 years) (% = Mean % of responses)
FIGURE 2
FIGURE 2
Geographical distribution of (A) epidemiological studies, (B) clinical trials, (C) local and regional research initiatives, and (D) government policies to support dementia in LACs. Data used to build this figure can be found in the Annexes 1 to 4
FIGURE 3
FIGURE 3
Knowledge‐to‐action framework. The diagram captures challenges posed by dementia and the related mapping of key actions. Such actions may be linked to specific working groups that have been included in the framework. This approach comprises a biomarker framework (LAC‐BF), genetics and epidemiology workgroup (LAC‐GEW), dementia platform (LAC‐DP), clinical trial program (LAC‐CTP), nonpharmacological interventions (LAC‐NPI), and an LAC network for translational research (LAC‐NTR)

Similar articles

  • Biomarkers for dementia in Latin American countries: Gaps and opportunities.
    Parra MA, Orellana P, Leon T, Victoria CG, Henriquez F, Gomez R, Avalos C, Damian A, Slachevsky A, Ibañez A, Zetterberg H, Tijms BM, Yokoyama JS, Piña-Escudero SD, Cochran JN, Matallana DL, Acosta D, Allegri R, Arias-Suárez BP, Barra B, Behrens MI, Brucki SMD, Busatto G, Caramelli P, Castro-Suarez S, Contreras V, Custodio N, Dansilio S, la Cruz-Puebla M, de Souza LC, Diaz MM, Duque L, Farías GA, Ferreira ST, Guimet NM, Kmaid A, Lira D, Lopera F, Meza BM, Miotto EC, Nitrini R, Nuñez A, O'Neill S, Ochoa J, Pintado-Caipa M, Resende EPF, Risacher S, Rojas LA, Sabaj V, Schilling L, Sellek AF, Sosa A, Takada LT, Teixeira AL, Unaucho-Pilalumbo M, Duran-Aniotz C. Parra MA, et al. Alzheimers Dement. 2023 Feb;19(2):721-735. doi: 10.1002/alz.12757. Epub 2022 Sep 13. Alzheimers Dement. 2023. PMID: 36098676 Free PMC article.
  • The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science.
    Ibanez A, Parra MA, Butler C; Latin America and the Caribbean Consortium on Dementia (LAC-CD). Ibanez A, et al. J Alzheimers Dis. 2021;82(s1):S379-S394. doi: 10.3233/JAD-201384. J Alzheimers Dis. 2021. PMID: 33492297 Free PMC article.
  • The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science.
    Ibanez A, Yokoyama JS, Possin KL, Matallana D, Lopera F, Nitrini R, Takada LT, Custodio N, Sosa Ortiz AL, Avila-Funes JA, Behrens MI, Slachevsky A, Myers RM, Cochran JN, Brusco LI, Bruno MA, Brucki SMD, Pina-Escudero SD, Okada de Oliveira M, Donnelly Kehoe P, Garcia AM, Cardona JF, Santamaria-Garcia H, Moguilner S, Duran-Aniotz C, Tagliazucchi E, Maito M, Longoria Ibarrola EM, Pintado-Caipa M, Godoy ME, Bakman V, Javandel S, Kosik KS, Valcour V, Miller BL. Ibanez A, et al. Front Neurol. 2021 Mar 11;12:631722. doi: 10.3389/fneur.2021.631722. eCollection 2021. Front Neurol. 2021. PMID: 33776890 Free PMC article. Review.
  • The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.
    Hartinger SM, Palmeiro-Silva YK, Llerena-Cayo C, Blanco-Villafuerte L, Escobar LE, Diaz A, Sarmiento JH, Lescano AG, Melo O, Rojas-Rueda D, Takahashi B, Callaghan M, Chesini F, Dasgupta S, Posse CG, Gouveia N, Martins de Carvalho A, Miranda-Chacón Z, Mohajeri N, Pantoja C, Robinson EJZ, Salas MF, Santiago R, Sauma E, Santos-Vega M, Scamman D, Sergeeva M, Souza de Camargo T, Sorensen C, Umaña JD, Yglesias-González M, Walawender M, Buss D, Romanello M. Hartinger SM, et al. Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
  • Dementia in Latin America: Assessing the present and envisioning the future.
    Parra MA, Baez S, Allegri R, Nitrini R, Lopera F, Slachevsky A, Custodio N, Lira D, Piguet O, Kumfor F, Huepe D, Cogram P, Bak T, Manes F, Ibanez A. Parra MA, et al. Neurology. 2018 Jan 30;90(5):222-231. doi: 10.1212/WNL.0000000000004897. Epub 2018 Jan 5. Neurology. 2018. PMID: 29305437 Free PMC article. Review.

Cited by

References

    1. Parra MA, Baez S, Allegri R, et al. Dementia in Latin America: assessing the present and envisioning the future. Neurology. 2018;90(5):222‐231. - PMC - PubMed
    1. Addressing global dementia. Lancet. 2014;383(9936):2185. - PubMed
    1. Alladi S, Hachinski V. World dementia: one approach does not fit all. Neurology. 2018;91(6):264‐270. - PubMed
    1. Dartigues JF. Alzheimer's disease: a global challenge for the 21st century. Lancet Neurol. 2009;8(12):1082‐1083. - PubMed
    1. Shah H, Albanese E, Duggan C, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016;15(12):1285‐1294. - PubMed

Publication types